Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Armagen, Inc.

Home Clinical Trial Sponsors and OrganizationsArmagen, Inc.

Armagen, Inc.

ACTIVE

12544 High Bluff Dr Ste 340, 加利福尼亚州洛杉矶县, California, United Stateswww.armagen.comSubsidiary11–50 employeesEstablished: 2001-01-01

Also known as:

armagen

Part of JCR Pharmaceuticals Co., Ltd.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

5

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2001

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

5

100.0%

Trial Status Distribution

Completed

5

100.0%

Clinical Trials

Trials sponsored by this organization (5)

Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I

Oct 201619 participants

Extension Study of AGT-181-102 to Evaluate Long Term Safety and Activity of AGT-181

Nov 20153 participants

Safety and Dose Ranging Study of Human Insulin Receptor MAb-IDUA Fusion Protein in Adults and Children With MPS I

Oct 201521 participants

Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I

Jul 20153 participants

Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome

Apr 20156 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials5
Approvals
News

Back to Organizations